Intelligence · Clinical Pipeline
TG THERAPEUTICS Pipeline
All ClinicalTrials.gov programs at TG THERAPEUTICS — phase, modality, and trial IDs.
- Programs
- 15
Quick answer
TG THERAPEUTICS has 15 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Azercabtagene zapreleucel (azer-cel)
TG THERAPEUTICS, INC.
B-cell Mediated Autoimmune Disorders
1 trial -
Cosibelimab
TG THERAPEUTICS, INC.
B-cell Non Hodgkin Lymphoma
1 trial -
DIPHENHYDRAMINE, METHYLPREDNISOLONE, PARACETAMOL, ublituximab, Ublituximab, ublituximab, CETIRIZINE, DEXAMETHASONE
TG THERAPEUTICS, INC.
Relapsing multiple sclerosis, Myasthenia Gravis
1 trial -
NM1F Injection
TG THERAPEUTICS, INC.
Ovarian Cancer
1 trial -
TG-1701
TG THERAPEUTICS, INC.
Non Hodgkin Lymphoma
1 trial -
TG-1801
TG THERAPEUTICS, INC.
B-Cell Lymphoma
1 trial -
TG-1801
TG THERAPEUTICS, INC.
CLL
1 trial -
TGI-5
TG THERAPEUTICS, INC.
CRC (Colorectal Cancer)
1 trial -
TGI-6 Injection
TG THERAPEUTICS, INC.
Advanced or Metastatic Solid Tumors
1 trial -
TGR-1202
TG THERAPEUTICS, INC.
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
1 trial -
TGR-1202
TG THERAPEUTICS, INC.
Non-Hodgkin's Lymphoma
1 trial -
TGR-1202
TG THERAPEUTICS, INC.
Pancreatic Cancer
1 trial -
TGR-1202 + Obinutuzumab + Chlorambucil
TG THERAPEUTICS, INC.
Chronic Lymphocytic Leukemia
1 trial -
TGR-1202 + brentuximab vedotin
TG THERAPEUTICS, INC.
Hodgkin's Lymphoma
1 trial -
Ublituximab + TGR-1202
TG THERAPEUTICS, INC.
Chronic Lymphocytic Leukemia
1 trial
Frequently asked questions
How many pipeline programs does TG THERAPEUTICS have?
15 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs